Antiretroviral pill count and clinical outcomes in treatment-naïve patients with HIV infection-Reference-Cited by-同舟云学术

Antiretroviral pill count and clinical outcomes in treatment-naïve patients with HIV infection

Published:2017-11-06 Issue:2 Volume:19 Page:132-142
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Young J¹,Smith C²,Teira R³,Reiss P⁴,Jarrín Vera I⁵,Crane H⁶,Miro JM⁷,D'Arminio Monforte A⁸,Saag M⁹,Zangerle R¹⁰,Bucher HC¹¹¹,

Affiliation:

1. Basel Institute for Clinical Epidemiology and Biostatistics; University Hospital Basel; Basel Switzerland

2. Research Department of Infection and Population Health; University College London; London UK

3. Unit of Infectious Diseases; Hospital Sierrallana; Torrelavega Spain

4. Department of Internal Medicine; Division of Infectious Diseases, Center for Infection and Immunity- Amsterdam; Academic Medical Center; Amsterdam The Netherlands

5. National Center of Epidemiology; Carlos III Health Institute; Madrid Spain

6. Center for AIDS Research; University of Washington; Seattle WA USA

7. Infectious Disease Service; The Hospital Clinic of Barcelona; August Pi i Sunyer Biomedical Research Institute; University of Barcelona; Barcelona Spain

8. Clinic of Infectious Diseases and Tropical Medicine; San Paolo Hospital; University of Milan; Milan Italy

9. Division of Infectious Disease; Department of Medicine; University of Alabama; Birmingham AL USA

10. Medical University Innsbruck; Innsbruck Austria

11. Division of Infectious Diseases and Hospital Epidemiology; University Hospital Basel; Basel Switzerland

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hiv.12562/fullpdf

Reference50 articles.

1. Systematic review and meta-analysis: patient and programme impact of fixed-dose combination antiretroviral therapy;Ramjan;Trop Med Int Health,2014

2. Hill A Generics - the facts 2015 http://www.bhiva.org/Presentations150422.aspx

3. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel;Thompson;Ann Intern Med,2012

4. Panel on Antiretroviral Guidelines for Adults and Adolescents Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents 2016 http://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf

5. European AIDS Clinical Society EACS guidelines, version 8.0 2015 http://www.eacsociety.org/files/guidelines_8_0-english_web.pdf

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure based design and evaluation of benzoheterocycle derivatives as potential dual HIV-1 protease and reverse transcriptase inhibitors;European Journal of Medicinal Chemistry;2023-01

2. Virological Outcomes After Switching to Abacavir/Lamivudine/Dolutegravir Combined with Adherence Support in People Living with HIV with Poor Adherence: A Phase IV, Multicentre Randomized Prospective Open Label Study (TriiADD-CTN 286);Patient Preference and Adherence;2022-12

3. Effect of single tablet regimen on prescription trends for treatment-naïve patients with HIV/AIDS in Korea;Scientific Reports;2022-02-07

4. High effectiveness of recommended first-line antiretroviral therapies in Germany: a nationwide, prospective cohort study;Infection;2020-05-11

5. A prospective randomized trial on abacavir/lamivudine plus darunavir/ritonavir or raltegravir in HIV-positive drug-naïve patients with CD4<200 cells/uL (the PRADAR study);PLOS ONE;2019-09-27